| Gadolinium-based contrast agent toxicity: a review of known and proposed mechanisms M Rogosnitzky, S Branch Biometals 29 (3), 365-376, 2016 | 854 | 2016 |
| Low-dose naltrexone therapy improves active Crohn's disease JP Smith, H Stock, S Bingaman, D Mauger, M Rogosnitzky, IS Zagon Official journal of the American College of Gastroenterology| ACG 102 (4 …, 2007 | 195 | 2007 |
| Therapeutic potential of the biscoclaurine alkaloid, cepharanthine, for a range of clinical conditions M Rogosnitzky, R Danks Pharmacological reports 63 (2), 337-347, 2011 | 124 | 2011 |
| Cepharanthine: A review of the antiviral potential of a Japanese-approved alopecia drug in COVID-19 M Rogosnitzky, P Okediji, I Koman Pharmacological Reports 72 (6), 1509-1516, 2020 | 95 | 2020 |
| Imiquimod upregulates the opioid growth factor receptor to inhibit cell proliferation independent of immune function IS Zagon, RN Donahue, M Rogosnitzky, PJ Mclaughlin Experimental biology and medicine 233 (8), 968-979, 2008 | 80 | 2008 |
| Therapeutic potential of tranilast, an anti-allergy drug, in proliferative disorders M Rogosnitzky, R Danks, E Kardash Anticancer Research 32 (7), 2471-2478, 2012 | 79 | 2012 |
| The impact of hospital volume and Charlson score on postoperative mortality of proctectomy for rectal cancer: a nationwide study of 45,569 patients M El Amrani, G Clement, X Lenne, M Rogosnitzky, D Theis, FR Pruvot, ... Annals of surgery 268 (5), 854-860, 2018 | 61 | 2018 |
| Noscapine inhibits human prostate cancer progression and metastasis in a mouse model I Barken, J Geller, M Rogosnitzky Anticancer research 28 (6A), 3701-3704, 2008 | 61 | 2008 |
| Delivering benefits at speed through real-world repurposing of off-patent drugs: the COVID-19 pandemic as a case in point M Rogosnitzky, E Berkowitz, AR Jadad JMIR Public Health and Surveillance 6 (2), e19199, 2020 | 54 | 2020 |
| Intravenous immunoglobulin for the treatment of Crohn's disease M Rogosnitzky, R Danks, D Holt Autoimmunity reviews 12 (2), 275-280, 2012 | 39 | 2012 |
| Reemergence of splenectomy for ITP second-line treatment? C Chater, L Terriou, A Duhamel, D Launay, JP Chambon, FR Pruvot, ... Annals of Surgery 264 (5), 772-777, 2016 | 36 | 2016 |
| Opioid growth factor (OGF) for hepatoblastoma: a novel non-toxic treatment M Rogosnitzky, MJ Finegold, PJ McLaughlin, IS Zagon Investigational new drugs 31, 1066-1070, 2013 | 36 | 2013 |
| Outcome in porcine acellular dermal matrix reinforcement of infected abdominal wall defects: a prospective study P Zerbib, R Caiazzo, G Piessen, M Rogosnitzky, C Séquier, D Koriche, ... Hernia 19, 253-257, 2015 | 26 | 2015 |
| Validation of blood testing for K-ras mutations in colorectal and pancreatic cancer M Rogosnitzky, R Danks Anticancer research 30 (7), 2943-2947, 2010 | 25 | 2010 |
| Conservative management of severe caustic injuries during acute phase leads to superior long-term nutritional and quality of life (QoL) outcome K Raynaud, D Seguy, M Rogosnitzky, F Saulnier, FR Pruvot, P Zerbib Langenbeck's archives of surgery 401, 81-87, 2016 | 20 | 2016 |
| Prophylactic noscapine therapy inhibits human prostate cancer progression and metastasis in a mouse model I Barken, J Geller, M Rogosnitzky Anticancer research 30 (2), 399-401, 2010 | 18 | 2010 |
| Rituximab for treating CD20+ prostate cancer with generalized lymphadenopathy: a case report and review of the literature A Dalgleish, P Featherstone, V Vlassov, M Rogosnitzky Investigational new drugs 32, 1048-1052, 2014 | 17 | 2014 |
| Intraplatelet vascular endothelial growth factor and platelet-derived growth factor: new biomarkers in carcinoembryonic antigen-negative colorectal cancer? C Chater, A Bauters, C Beugnet, L M’Ba, M Rogosnitzky, P Zerbib Gastrointestinal tumors 5 (1-2), 32-37, 2018 | 14 | 2018 |
| Pterygium: Nonsurgical treatment using topical dipyridamole-a case report BH Carlock, CA Bienstock, M Rogosnitzky Case reports in ophthalmology 5 (1), 98-103, 2014 | 14 | 2014 |
| Efficacy of sacral nerve stimulation for poor functional results of J-pouch ileoanal anastomosis A Lebas, M Rogosnitzky, C Chater, JF Colombel, M Nachury, A Cortot, ... Techniques in coloproctology 18, 355-360, 2014 | 14 | 2014 |
Alejandro R JadadFounder, Centre for Digital Therapeutics在 vivenxia.com 的电子邮件经过验证
